Krystle Zuniga

Dr. Krystle Zuniga

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2011 in Nutrition and Cancer
Verified
Journal Article
Closed access
NFNikki A. Ford
Nikki A. Ford
AEAmy C. Elsen
Amy C. Elsen
KZKrystle Zuniga
Krystle Zuniga
BLBrian L. Lindshield
Brian L. Lindshield
JEJohn W. Erdman
John W. Erdman
Lycopene is associated with a reduced risk of prostate cancer. However, lycopene may not be wholly responsible for the effects seen in vivo or in cell culture systems. Apo-lycopenals or other lycopene metabolites, whether produced by cleavage enzymes within the body or consumed with tomato products, can be found in tissues at concentrations equivalent to physiological retinoid concentrations. Therefore, it is plausible that lycopenoids, like retinoids, are bioactive within tissues. Androgen-independent DU145 prostate cancer cells were treated with lycopene, apo-8′-lycopenal, or apo-12′-lycopenal. DU145 cell proliferation was significantly reduced by supra-physiological levels of lycopene and apo-12′-lycopenal, in part, through alteration of the normal cell cycle. Levels of the gap junction protein, connexin 43, were unaltered by lycopene or apo-lycopenal treatment while cell apoptosis rates significantly decreased. We further confirmed that connexin 43 protein levels were unaltered by lycopene treatment in mouse embryonic fibroblasts, or in Dunning R3327-H rat prostate tumor. The present data indicate that lycopene and apo-12′-lycopenal reduce the proliferation of prostate cancer cells, in part, by inhibiting normal cell cycle progression.

26 September 2018 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
KZKrystle Zuniga
Krystle Zuniga
DPDorothy Long Parma
Dorothy Long Parma
EMEdgar Muñoz
Edgar Muñoz
MSMackenzie Spaniol
Mackenzie Spaniol
MWMichael Wargovich
Michael Wargovich
ARAmelie G. Ramirez
Amelie G. Ramirez

30 July 2014 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
EAElizabeth A. Awick
Elizabeth A. Awick
TWThomas R. Wójcicki
Thomas R. Wójcicki
EOErin A. Olson
Erin A. Olson
JFJason Fanning
Jason Fanning
HCHyondo D. Chung
Hyondo D. Chung
EMEdward McAuley
Edward McAuley

3 March 2015 in Psychogeriatrics
Verified
Journal Article
Closed access
PDF file
KZKrystle Zuniga
Krystle Zuniga
MMMichael J. Mackenzie
Michael J. Mackenzie
AKArt Kramer
Art Kramer
EMEdward McAuley
Edward McAuley

5 December 2014 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
PDF file
KZKrystle Zuniga
Krystle Zuniga
EME. McAuley
E. McAuley
Older adults are the most rapidly growing age group in the United States, and it is estimated that 22.2% of U.S. adults over 71 years of age have cognitive impairments without dementia and 13.9% have dementia. Cognitive impairment is associated with reduced quality of life, increased risk of hospitalization, inability to live independently, and increased health care costs; therefore, identification of modifiable risk factors for prevention and delay of cognitive decline is of increasing importance. There is a growing body of research and interest in the relationship between diet and cognitive function. Epidemiologic studies suggest that cognitive function may be improved and cognitive decline prevented as a function of a particular nutrient, food group or dietary pattern; however, results from these trials have failed to be replicated in randomized controlled trials. One possible reason for the equivocality of findings in the diet and cognitive function literature may be the methodological issues and limitations in the assessment of dietary patterns and nutritional intake. Self-reported dietary data can be biased by many factors such as age, gender, socioeconomic status, and education; yet, there is limited research on the impact of cognitive function on the integrity of self-reported dietary data. Cognitive function itself may bias diet assessment methods, subsequently obscuring the evaluation of the nutrition-cognition relationship. The present review summarizes methodological validation studies that provide insight into potential errors of diet assessment methods due to cognitive function, identifies research gaps and provides recommendations for improving diet assessment accuracy in studies of individuals with cognitive impairments.

1 June 2013 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
KZKrystle Zuniga
Krystle Zuniga
SCSteven K. Clinton
Steven K. Clinton
JEJohn Erdman
John Erdman
The interactions between bioactive-rich food components within a complex human diet for the inhibition of prostate carcinogenesis are largely unknown and difficult to quantify in humans. Tomato and soy products have each shown anti-prostate cancer (PCa) activity in laboratory studies. The objective of this study was to determine the efficacy of dietary tomato and soy germ, alone and in combination, for the inhibition of PCa in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. At 4 weeks of age, male C57BL/6 × FVB TRAMP mice (n = 119) were randomized to consume: AIN-93G control, 10% whole tomato powder (TP), 2% soy germ powder (SG), or 10% tomato powder with 2% soy germ powder (TP+SG) for 14 weeks. One hundred percent of mice fed the control diet had PCa, whereas PCa incidence was significantly lower in mice consuming TP (61%, P < 0.001), SG (66%, P < 0.001), and TP+SG (45%, P < 0.001). Although the protection offered by the combination of TP and SG was not synergistic, it was the most effective intervention. TP, SG, and TP+SG increased apoptotic index (AI) and modestly reduced the proliferative index (PI) in the prostate epithelium of TRAMP mice exhibiting primarily prostatic intraepithelial neoplasia. The dramatic reduction in the PI/AI ratio by the dietary interventions suggests that the control mice experience a stronger stimulus for malignant progression in the prostate microenvironment. Maximally effective and safe strategies for PCa prevention may result from optimizing combinations of nutrients and bioactives through an orchestration of dietary patterns. Cancer Prev Res; 6(6); 548–57. ©2013 AACR.